Atlas Trials

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)

Clinical trial NCT01430195 · COMPLETED

Trial details

NCT number
NCT01430195
Sponsor
Clinuvel Pharmaceuticals Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Vitiligo
Start date
2011-06-01
Primary completion
2012-05-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.